Merck MRK
NYSE MRK
$152.55 +3.56 (+2.39%)
At close: Aug 21, 2026 · 4:01 PM EDT

Merck (MRK) Goodwill & Intangibles (2009 - 2026)

Merck (MRK) posted quarterly Goodwill & Intangibles of $47.3 billion for Q1 2026, up 26.4% year-over-year from $37.4 billion in Q1 2025, and down 1.94% quarter-over-quarter from $48.3 billion in Q4 2025.

Merck (MRK) Goodwill & Intangibles (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Goodwill & Intangibles for 18 consecutive years, with $47.3 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles rose 26.4% year-over-year to $47.3 billion; the TTM figure through Mar 2026 stood at $47.3 billion (up 26.4% YoY), while the FY2025 annual figure was $48.3 billion, up 26.87% from the prior year.
  • Goodwill & Intangibles fell to $47.3 billion in Q1 2026 per MRK's latest filing, from $48.3 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $48.3 billion in Q4 2025 and bottomed at $36.8 billion in Q2 2025.
  • Historically, Goodwill & Intangibles has averaged $40.8 billion across 5 years, with a median of $40.4 billion in 2023.
  • Annual changes were most pronounced in 2022 — Goodwill & Intangibles soared 34.51% — and 2023, when it decreased 7.26%.
  • Merck's Goodwill & Intangibles stood at $41.5 billion in 2022, then fell by 5.46% to $39.2 billion in 2023, then slipped by 2.98% to $38.0 billion in 2024, then gained by 26.87% to $48.3 billion in 2025, then declined by 1.94% to $47.3 billion in 2026.
  • Business Quant data shows MRK's Goodwill & Intangibles at $47.3 billion in Q1 2026, $48.3 billion in Q4 2025, and $36.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 46.56 Bn
Mar 31, 2026 47.33 Bn
Dec 31, 2025 48.26 Bn
Sep 30, 2025 36.90 Bn
Jun 30, 2025 36.78 Bn
Mar 31, 2025 37.44 Bn
Dec 31, 2024 38.04 Bn
Sep 30, 2024 38.71 Bn
Jun 30, 2024 38.15 Bn
Mar 31, 2024 38.75 Bn
Dec 31, 2023 39.21 Bn
Sep 30, 2023 40.38 Bn
Jun 30, 2023 40.86 Bn
Mar 31, 2023 41.07 Bn
Dec 31, 2022 41.47 Bn
Sep 30, 2022 42.53 Bn
Jun 30, 2022 43.71 Bn
Mar 31, 2022 44.28 Bn
Dec 31, 2021 44.20 Bn
Sep 30, 2021 32.25 Bn